- Visibility 112 Views
- Downloads 96 Downloads
- Permissions
- DOI 10.18231/j.ijmr.89406.1758357916
-
CrossMark
Phenotypic detection of virulence attributes in MDR Acinetobacter from a tertiary care hospital, South India
- Author Details:
-
Monisha Basavaraju
-
Rashmi P Mahale *
-
M Raghavendra Rao
-
Suchitra Shenoy
Monisha Basavaraju
Rashmi P Mahale *
M Raghavendra Rao
Suchitra Shenoy
Background: The nosocomial pathogen Acinetobacter baumannii is found all over the world and has a number of virulence characteristics that enable them to render resistance to antibiotics, making them multidrug resistant.
Objectives: To detect the virulence attributes of MDR Acinetobacter baumannii isolated from a tertiary care hospital in South India.
Materials and Methods: This prospective study, conducted from August 2023 to October 2024, involved 55 clinical and 55 environmental multidrug-resistant (MDR) Acinetobacter baumannii isolates. The isolates were evaluated for virulence factors using phenotypic assays, which included siderophore production assessed on Chrome Azurol S (CAS) agar, hemolytic activity on blood agar, proteolytic activity on milk agar, and biofilm formation using the tissue culture plate method.
Results: All clinical and environmental MDR A. baumannii isolates exhibited intermediate susceptibility to colistin. Tigecycline sensitivity was observed in 78% of the clinical isolates and 52.27% of the environmental isolates. Of the 55 clinical isolates of MDR A. baumannii, 34 (61.81%) showed biofilm production, 20 (36.36%) showed haemolytic activity, 29(52.72%) showed proteolytic activity and 30 (54.54%) showed siderophore production. Similarly, among the 55 Environmental isolates, 24 (43.63%) showed biofilm production, 15 (27.27%) showed haemolytic activity 31(56.36%) showed proteolytic activity and 19 (34.54%) showed siderophore production.
Conclusion: This study shows that the clinical MDR A. baumannii strains were more virulent than the environmental strains, thereby highlights its evolving virulence and resistance. This study also stresses the importance of continued surveillance, infection control practices and responsible antibiotic use in clinical setting.
References
- Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7:55.
- Nemec A, Krizova L, Maixnerova M, Sedo O, Brisse S, Higgins PG. Acinetobacter seifertii sp. nov., a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated from human clinical specimens. Int J Syst Evol Microbiol. 2015;65(Pt 3):934–42.
- Vijayakumar S, Mathur P, Kapil A, Das BK, Ray P, Gautam V, et al. Molecular characterization & epidemiology of carbapenem- resistant Acinetobacter baumannii collected across India. Indian J Med Res. 2019;149(2):240–6.
- Holt K, Kenyon JJ, Hamidian M, Schultz MB, Pickard DJ, Dougan G, et al. Five decades of genome evolution in the globally distributed, extensively antibiotic-resistant Acinetobacter baumannii global clone 1. Microb Genom. 2016;2(2):e000052.
- Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557–96.
- Fleming ID, Krezalek MA, Belogortseva N, Zaborin A, Defazio J, Chandrasekar L, et al. Modeling Acinetobacter baumannii wound infections: the critical role of iron. J Trauma Acute Care Surg. 2017;82(3):557–65.
- Rumbo-Feal S, Gómez MJ, Gayoso C, Álvarez-Fraga L, Cabral MP, Aransay AM, et al. Whole transcriptome analysis of Acinetobacter baumannii assessed by RNA-sequencing reveals different mRNA expression profiles in biofilm compared to planktonic cells. PLoS One. 2013;8(8):e72968.
- Thummeepak R, Kongthai P, Leungtongkam U, Sitthisak S. Distribution of virulence genes involved in biofilm formation in multi-drug resistant Acinetobacter baumannii clinical isolates. Int Microbiol. 2016;19(2):121–9.
- Amin M, Navidifar T, Shooshtari FS, Rashno M, Savari M, Jahangirmehr F, et al. Association between biofilm formation, structure, and the expression levels of genes related to biofilm formation and biofilm-specific resistance of Acinetobacter baumannii strains isolated from burn infection in Ahvaz, Iran. Infect Drug Resist. 2019;12:3867–81.
- Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018;16(2):91–102.
- Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN, Gerstein M, et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 2007;21(5):601–14.
- Antunes LC, Imperi F, Carattoli A, Visca P. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One. 2011;6(8):e22674.
- Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–82.
- Eze EC, Chenia HY, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist. 2018;11:2277–99.
- BioMérieux. BioMérieux, India [Internet]. BioMérieux. Available from: https://www.biomerieux.com/corp/en.html.
- Christensen GD, Simpson WA, Younger JA, Baddour LM, Barrett FF, Melton DM, et al. Adherence of coagulase negative staphylococci to plastic tissue cultures: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985;22(6):996–1006.
- Harika K, Shenoy VP, Narasimhaswamy N, Chawla K. Detection of biofilm production and its impact on antibiotic resistance profile of bacterial isolates from chronic wound infections. J Glob Infect Dis. 2020;12(3):129–34.
- HiMedia Laboratories Pvt Ltd, India. Available from: https://www.himedialabs.com
- Boulesnam SL, Hamaidi-Chergui F, Benamara M, Azrou S. Phenotypical comparison between environmental and clinical Acinetobacter baumannii strains isolated from an intensive care unit. Malays J Med Sci. 2023;30(4):85–93.
- Yadav SK, Bhujel R, Hamal P, Mishra SK, Sharma S, Sherchand JB. Burden of multidrug-resistant Acinetobacter baumannii infection in hospitalized patients in a tertiary care hospital of Nepal. Infect Drug Resist. 2020;13:725–32.
- Bardbari AM, Arabestani MR, Karami M, Keramat F, Alikhani MY, Bagheri KP. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates. Microb Pathog. 2017;108:122–8. Basavaraju et al. / Indian Journal of Microbiology Research 2025;12(3):357–363 363
- Pournaras S, Zarrilli R, Higgins PG, Tsioutis C. Editorial: carbapenemase-producing organisms as leading cause of hospital infections. Front Med. 2021;8:775021.
- Martínez-Trejo A, Ruiz-Ruiz JM, Gonzalez-Avila LU, Saldaña- Padilla A, Hernández-Cortez C, Loyola-Cruz MA, et al. Evasion of antimicrobial activity in Acinetobacter baumannii by target site modifications: an effective resistance mechanism. Int J Mol Sci. 2022;23(12):6582.
- Lee YH. Siderophore production by Acinetobacter baumannii clinical isolates and its correlation with antimicrobial resistance. J Antimicrob Chemother. 2019;74(3):726–31.
- Zong Z. Characterization of siderophore production in MDR Acinetobacter baumannii clinical isolates. J Clin Microbiol. 2018;56(5):e01892–17.
- Catalano A, Iacopetta D, Ceramella J, Scumaci D, Giuzio F, Saturnino C, et al. Multidrug resistance (MDR): a widespread phenomenon in pharmacological therapies. Molecules. 2022;27(3):616. Cite this article: Basavaraju M, Mahale RP, Rao MR, Shenoy S. Phenotypic detection of virulence attributes in MDR Acinetobacter from a tertiary care hospital, South India. Indian J Microbiol Res. 2025;12(3):357–363.